HPTLC method for the simultaneous determination of amlodipine and benazepril in their formulations.

J Chromatogr Sci

Department of Pharmaceutical Chemistry, J.S.S. College of Pharmacy, Ootacamund D 643 001, Tamilnadu, India.

Published: February 2005

A new, simple, precise, rapid, and selective high-performance thin-layer chromatographic (HPTLC) method is developed for the simultaneous analysis of amlodipine and benazepril in pharmaceutical formulations. The method uses zolpidem as an internal standard (IS). The stationary phase used is silica gel 60 F254 prewashed with methanol. The mobile phase consists of an ethyl acetate-methanol-ammonia solution (8.5:2.0:1.0, v/v/v). Detection and quantitation are performed densitometrically at lambda = 254 nm. The Rf values of amlodipine, benazepril, and zolpidem (IS) are 0.58, 0.50, and 0.78, respectively. The limits of detection of amlodipine and benazepril are 0.02 and 0.2 microg; linearity ranges are 0.1-0.8 and 0.2-2.0 microg; and the percentage recoveries are 99.79% and 100.25%, respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1093/chromsci/43.2.73DOI Listing

Publication Analysis

Top Keywords

amlodipine benazepril
16
hptlc method
8
method simultaneous
4
simultaneous determination
4
amlodipine
4
determination amlodipine
4
benazepril
4
benazepril formulations
4
formulations simple
4
simple precise
4

Similar Publications

Background: Acute declines in estimated glomerular filtration rate (eGFR) occur commonly after starting angiotensin-converting enzyme inhibitors. Whether declines in eGFR that occur after simultaneously starting angiotensin-converting enzyme inhibitors with other antihypertensive agents modifies the benefits of these agents on cardiovascular outcomes is unclear.

Methods And Results: We identified predictors of acute declines in eGFR (>15% over 3 months) during randomization to benazepril plus amlodipine versus benazepril plus hydrochlorothiazide in the ACCOMPLISH (Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension) trial.

View Article and Find Full Text PDF
Article Synopsis
  • BRASH syndrome is a serious condition characterized by a cycle of high potassium levels (hyperkalemia) and slow heart rate (bradycardia), often triggered by low blood volume or existing high potassium levels.
  • A case study of a 92-year-old man with heart issues showed how he developed BRASH syndrome following diarrhea, which led to dangerously low blood pressure and heart rate, along with rising potassium levels.
  • Treatment involved several interventions, including intravenous medications, and after 5 hours, his heart rate and potassium levels stabilized, illustrating the importance of early diagnosis and intervention for better patient outcomes.
View Article and Find Full Text PDF

Evaluation of a miniature mass spectrometer based point-of-care-test method for direct analysis of amlodipine and benazepril in whole blood.

J Pharm Biomed Anal

August 2024

Panvascular Diseases Research Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China; Laboratory of Food Nutrition and Clinical Research, Institute of Seafood, Zhejiang Gongshang University, Hangzhou, China. Electronic address:

A miniature mass spectrometer (mMS) based point-of-care testing (POCT) method was evaluated for on-site detecting the hypertension drugs, amlodipine and benazepril. The instrument parameters, including voltage, ISO1, ISO2, and CID, were optimized, under which the target compounds could be well detected in MS. When these two drugs were injected simultaneously, the mutual ionization inhibition and mutual reduction between amlodipine and benazepril were evaluated.

View Article and Find Full Text PDF

Hypercortisolism in dogs is frequently associated with systemic hypertension (SH). However, there are no studies evaluating the changes in systolic blood pressure (SBP) in dogs with adrenal-dependent hypercortisolism (ADH) during trilostane treatment or after adrenalectomy and their response to antihypertensive treatments. For this reason, the objectives of this study were to evaluate the changes in SBP in dogs with ADH during the first year of trilostane treatment or after adrenalectomy, the relation with clinical control of hypercortisolism and certain laboratory parameters, and the response to antihypertensive drugs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!